Li Xiaowei, member of the Party Working Committee and deputy director of the Management Committee of Zhengzhou Zhongyuan Science and Technology City, and his party visited Yinfeng Biological Group for discussion and exchange
Release time:
2022-08-23
On August 23, Li Xiaowei, member of the Party Working Committee and deputy director of the Management Committee of Zhengzhou Zhongyuan Science and Technology City, Zhang Xu, deputy director of the Investment Promotion Service Bureau of the Zhengzhou Zhongyuan Science and Technology City Management Committee, and Wang Lin, chief of the Investment Promotion Service Bureau of the Zhengzhou Zhongyuan Science and Technology City Management Committee, visited Yinfeng Biological Group for discussion and exchange.
Zhang Cheng, Vice President of Yinfeng Biological Group, Shan Changfeng, Director of Investment and Development Department of Yinfeng Real Estate Group, and Yu Shuijun, Director of Marketing Department of Yinfeng Biological Group, accompanied the visit.
The delegation visited the "Infinite Life Plan" Science Museum and the "Life Extension Plan" exhibition hall successively, and learned in detail about the storage and application prospects of cells in 5G scenarios, the application of cryogenic medicine, the first case of human cryopreservation in Asia, and the infinite possibilities of cryomedicine in organ transplantation and clinical applications.
The delegation visited this time to learn about the industrial layout, cutting-edge technology, R&D and innovation, and achievement transformation of Yinfeng Biological Group in the biomedical field. He highly recognized and praised the achievements of Yinfeng Biological Group. Yinfeng Biological Group is a high-tech enterprise specializing in technology research and development, medical transformation and clinical research in the biomedical field such as human cells, tissues and organ storage, gene sequencing technology, cell application technology, cryogenic medical technology and health management services. In the past 19 years, Yinfeng Biotech has taken the lead in opening up the health management service industry chain covering the whole life cycle of human beings in the country, with the development vision of "becoming a leading domestic and international first-class health management service provider for the whole life cycle of human beings", and contributing to the service of "Healthy China".
Previous article
Previous article
Latest developments
Over the two days, the symposium was not only a collision of ideas but also seeds sown to advance social progress in life culture. The Shandong Yinfeng Life Science Public Welfare Foundation will continue to use technology as wings and culture as roots, collaborating with all sectors of society to enhance the quality of life for the Chinese people and build a human-centered life care system.
According to recent announcements by the Jinan Municipal Bureau of Science and Technology, 11 outstanding achievements from Jinan have been included in the 2025 "Shandong Outstanding Achievements Report" project. Among them is the globally first-of-its-kind ovarian tissue dual-activation technology developed by Shandong Silver Med Life Science Research Institute (Jinan).
Recently, Frigid Zone Medicine, an authoritative international journal in the field of cryomedicine, published an important review titled "Advances in the Detection Methods for Assessing the Viability of Cryopreserved Samples". Written by the team of Yinfeng Cryomedical Research Center, the article systematically reviews and analyzes various detection techniques currently used to evaluate the viability of cryopreserved cells, tissues, and organs. It also proposes key directions from the perspectives of methodological integration and future instrument development, offering crucial theoretical support and practical guidance for the long - term cryopreservation of complex tissues and organs.
Recently, the "Novel Technology for Ultra-Low Temperature Cryopreservation, Activation, and Transplantation of Human Ovarian Tissue," developed through a collaborative effort between Shandong Yinfeng Life Science Research Institute and Beijing University of Chinese Medicine Shenzhen Hospital, has been awarded the 2025 Shandong Refrigeration and Air Conditioning Science and Technology Award. This groundbreaking technology pioneers a new pathway for female fertility preservation, marking a significant leap in China’s interdisciplinary advancements in reproductive medicine and cryobiology.
On May 19, a delegation from the Chinese Training Workshop for Government Officials of Developing Countries visited the exhibition hall of Yinfeng Biological Group's Cryomedicine Research Center. Government officials from multiple countries gained in-depth insights into Yinfeng’s innovative achievements in cryobiomedicine, cell storage, genetic technology, and other fields. They engaged in discussions with the delegation on technology transfer and international cooperation, contributing to the building of a global community with a shared future for humanity.
Yinfeng Life Continuation Plan
Address: Yinfeng Biotechnology Park, 1758 Gangyuan 6th Road, High-tech Zone, Jinan City, Shandong Province
Zip Code: 250102
Telephone: 0086-0531-88897351
Mobile: 0086-19953155507
Mobile website
Official WeChat Public Number
Links:Red Cross Society of China丨Shandong Red Cross Society丨Shandong Provincial Health Commission | Yinfeng Group| Yinfeng Biological Group
All rights reserved©Yinfeng Life Continuation Powered by www.300.cn SEO
